1411867-74-7

1411867-74-7 structure

Name: Asenapine citrate
Chemical Name: Asenapine citrate
CAS Number: 1411867-74-7
Molecular Formula: C₂₃H₂₄ClNO₈
Molecular Weight: 477.89
Catalog: Signaling Pathways GPCR/G Protein 5-HT Receptor
Create Date: 2022-08-16 11:15:40
Modify Date: 2025-08-26 23:34:15
Asenapine citrate, an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0). Asenapine citrate can be used in the research of schizophrenia and bipolar disorder[1][2].

Name	Asenapine citrate

Description	Asenapine citrate, an atypical antipsychotic, is an antagonist of serotonin receptors (pKi: 8.4-10.5), adrenoceptors (pKi: 8.9-9.5), dopamine receptors (pKi: 8.9-9.4) and histamine receptors (pKi: 8.2-9.0). Asenapine citrate can be used in the research of schizophrenia and bipolar disorder[1][2].
Related Catalog	Signaling Pathways >> Immunology/Inflammation >> Histamine Receptor Signaling Pathways >> GPCR/G Protein >> Dopamine Receptor Signaling Pathways >> GPCR/G Protein >> Adrenergic Receptor Signaling Pathways >> Neuronal Signaling >> Dopamine Receptor Research Areas >> Neurological Disease Signaling Pathways >> GPCR/G Protein >> 5-HT Receptor Signaling Pathways >> Neuronal Signaling >> 5-HT Receptor Signaling Pathways >> GPCR/G Protein >> Histamine Receptor
Target	5-HT1A Receptor:8.6 (pKi) 5-HT1B Receptor:8.4 (pKi) 5-HT2A Receptor:10.2 (pKi) 5-HT2B Receptor:9.8 (pKi) 5-HT2C Receptor:10.5 (pKi) 5-HT5 Receptor:8.8 (pKi) 5-HT6 Receptor:9.6 (pKi) 5-HT7 Receptor:9.9 (pKi) α1-adrenergic receptor:8.9 (pKi) Alpha-2A adrenergic receptor:8.9 (pKi) Alpha-2B adrenergic receptor:9.5 (pKi) Alpha-2C adrenergic receptor:8.9 (pKi) D1 Receptor:8.9 (pKi) D2 Receptor:8.9 (pKi) D3 Receptor:9.4 (pKi) D4 Receptor:9.0 (pKi) H1 Receptor:9.0 (pKi) H2 Receptor:8.2 (pKi)
In Vivo	Asenapine (0.05-0.2 mg/kg; s.c.) induces a dose-dependent suppression of conditioned avoidance response (CAR) and does not induce catalepsy[2].
References	[1]. M Shahid, et al. Asenapine: a novel psychopharmacologic agent with a unique human receptor signature. J Psychopharmacol. 2009 Jan;23(1):65-73. [2]. Olivia Frånberg, et al. Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia. Psychopharmacology (Berl). 2008 Feb;196(3):417-29.

Molecular Formula	C₂₃H₂₄ClNO₈
Molecular Weight	477.89

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1411867-74-7	165890-07-3
85650-56-2	1399103-21-9
128949-51-9	1180843-72-4
1412458-61-7	65576-45-6
1587-20-8	919-16-4
917494-85-0	1219454-52-0
1027706-07-5	1219454-19-9
1219454-21-3	1027712-06-6
1219454-54-2	1279868-62-0
1219454-47-3	1219454-38-2